XRP Drops 11% After U.S. Senate Fails to Advance CLARITY Act
XRP fell 10.58% on September 15, 2026, after the U.S. Senate failed to advance the CLARITY Act, a regulatory proposal for the crypto industry.
By Muhamed Porić
October 13, 2026 at 11:56 AM

XRP fell 10.58% on September 15, 2026, marking its largest single-day decline since February 2026. The sell-off followed the U.S. Senate's failure to advance the CLARITY Act, a legislative proposal that market participants viewed as an indicator for future regulatory status in the digital asset space.
"The legislative setback triggered a wave of market uncertainty, causing investors to reevaluate positions in assets heavily tied to U.S. regulatory developments," according to a market analysis report.
Market Impact and Capitalization
Following the legislative news, XRP traded at $1.3216. The decline affected the cryptocurrency sector, as the asset's market capitalization contracted to $86.9 billion. This figure represents 3.34% of the total cryptocurrency market capitalization, according to data from Investing.com.
Historical Performance Context
Despite recent volatility, the asset remains below its historical peak. At its current price, XRP is down 63.85% from its all-time high of $3.66, which was recorded on July 18, 2025.
What Is at Stake for Digital Assets
The CLARITY Act was intended to establish a framework for the classification and oversight of digital tokens, which many industry participants argue is necessary for institutional adoption. The failure of the Senate to advance the measure has increased concerns regarding the regulatory environment for blockchain-based projects in the United States. For market observers, the price action shows how legislative developments influence asset liquidity and valuation in an environment where regulatory status remains a driver of investor sentiment.
Muhamed Porić
Founder and Editor of Embers.
Newsletter
Get Embers in your inbox
The stories that actually moved something, delivered when there's something worth sending, not daily filler.